Taher Hatahet

Taher Hatahet is a Senior Lecturer at North Wales Medical School, Wrexham University, specializing in pharmaceutical technology and drug delivery systems. His academic journey includes a PhD in pharmaceutical technology from Université de Montpellier (2016), a Postgraduate Certificate in Higher Education Teaching from Queen's University Belfast (2020), and a Professional HEA fellowship (2020). His research activities have shown significant growth, with 16 publications listed for 2025 alone, reflecting his active contribution to the field.

His educational background demonstrates a strong foundation in both pharmaceutical sciences and pedagogy, with expertise spanning from drug formulation to educational methodologies. His commitment to advancing pharmaceutical education is evident through his development of blended learning models and focus on student engagement strategies.

Dr. Hatahet's research interests center on nanotechnology-based drug delivery systems, particularly for poorly water-soluble and biopharmaceutical compounds. His work explores innovative approaches to enhance drug efficacy through advanced formulation techniques, including lipid nanocapsules and liposomal systems. A significant portion of his recent research focuses on photothermal therapy applications using indocyanine green for cancer treatment, demonstrating promising results in melanoma models. He also maintains an active interest in pharmaceutical education, developing strategies to enhance student engagement and learning outcomes in transnational educational contexts.

His publication record reveals a clear trend toward increasingly sophisticated drug delivery systems with therapeutic applications in oncology, particularly in photothermal therapy and cancer vaccine development. The research spans both fundamental pharmaceutical science (formulation development, physicochemical characterization) and translational applications (in vitro and in vivo testing).

Dr. Hatahet demonstrates a commitment to addressing global challenges through his work on rebuilding higher education in Syria and improving healthcare education in conflict zones. His research output shows consistent growth, with a notable increase in publications from 2022 onward, indicating an expanding research program with significant collaborative networks.

His supervisory role includes accepting PhD students for projects related to nanotechnology-based drug delivery systems, particularly focusing on poorly water-soluble drugs, biopharmaceuticals, and cellular testing of formulations. His educational innovations include developing active learning opportunities with feedback mechanisms to enhance student achievement in pharmaceutical innovation modules.

His laboratory work appears to focus on formulation development, physicochemical characterization, and in vitro cellular testing of drug delivery systems, with potential collaborations extending to in vivo studies and ligand synthesis for targeted drug delivery.